These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial. Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM; Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715 [TBL] [Abstract][Full Text] [Related]
23. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome. Hemingway-Eltomey JM; Lerner AJ Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967 [No Abstract] [Full Text] [Related]
24. Aggressive behaviour associated with donepezil treatment: a case report. Bianchetti A; Trabucchi M; Cipriani G Int J Geriatr Psychiatry; 2003 Jul; 18(7):657-8. PubMed ID: 12833312 [No Abstract] [Full Text] [Related]
25. Intraoperative floppy-iris syndrome associated with chronic intake of donepezil. Papadopoulos R; Bachariou A J Cataract Refract Surg; 2007 Nov; 33(11):1997-8. PubMed ID: 17964415 [No Abstract] [Full Text] [Related]
26. Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern. Wolff ML Am J Geriatr Pharmacother; 2012 Jun; 10(3):219-22. PubMed ID: 22445625 [TBL] [Abstract][Full Text] [Related]
27. Donepezil and cardiac syncope: case report. Jane Newby V; Anne Kenny R; McKeith IG Int J Geriatr Psychiatry; 2004 Nov; 19(11):1110-2. PubMed ID: 15497193 [No Abstract] [Full Text] [Related]
29. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan. Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907 [TBL] [Abstract][Full Text] [Related]
30. Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents. Burt T Curr Psychiatry Rep; 2000 Dec; 2(6):473-8. PubMed ID: 11122998 [TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant-like syndrome due to donepezil and maprotiline. Ohkoshi N; Satoh D; Nishi M; Shoji S Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986 [No Abstract] [Full Text] [Related]
36. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia]. Edhag O; Norlund A Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745 [No Abstract] [Full Text] [Related]
37. Recurrence of upper gastrointestinal bleeding after donepezil administration. Cholongitas E; Pipili C; Dasenaki M Alzheimer Dis Assoc Disord; 2006; 20(4):326. PubMed ID: 17132985 [No Abstract] [Full Text] [Related]
38. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors. Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643 [TBL] [Abstract][Full Text] [Related]
39. Update on Alzheimer drugs (donepezil). Smith Doody R Neurologist; 2003 Sep; 9(5):225-9. PubMed ID: 12971832 [TBL] [Abstract][Full Text] [Related]
40. Advertisements for donepezil (Aricept) in the BMJ. Local committee has declined to approve NHS hospital prescription of donepezil. Wagner N BMJ; 1997 May; 314(7093):1555-6. PubMed ID: 9183223 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]